In Vivo Method to Monitor Changes in HER2 Expression Using Near-Infrared Fluorescence Imaging
Human epidermal growth factor receptor type 2 (HER2) is a well-known biomarker that is overexpressed in many breast carcinomas. HER2 expression level is an important factor to optimize the therapeutic strategy and monitor the treatment. We used albumin binding domain–fused HER2-specific Affibody mol...
Main Authors: | Moinuddin Hassan, Victor Chernomordik, Rafal Zielinski, Yasaman Ardeshirpour, Jacek Capala, Amir Gandjbakhche |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2012-05-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2011.00038 |
Similar Items
-
Quantitative Analysis of HER2 Receptor Expression In Vivo by Near-Infrared Optical Imaging
by: Victor Chernomordik, et al.
Published: (2010-07-01) -
In vivo fluorescence lifetime imaging monitors binding of specific probes to cancer biomarkers.
by: Yasaman Ardeshirpour, et al.
Published: (2012-01-01) -
Fluorescence Lifetime Imaging System for in Vivo Studies
by: Moinuddin Hassan, et al.
Published: (2007-07-01) -
Using in vivo fluorescence lifetime imaging to detect HER2-positive tumors
by: Yasaman Ardeshirpour, et al.
Published: (2018-04-01) -
In Vivo Tomographic Imaging of Near-Infrared Fluorescent Probes
by: Vasilis Ntziachristos, et al.
Published: (2002-04-01)